Potential Rebound for Underperforming Stocks in 2024 ?
Analysts from Jefferies believe that some stocks which struggled in 2024 may be poised for a comeback this year. Their analysis indicates a disconnect between high-performing stocks and those that lagged, suggesting that we may witness a convergence in performance moving forward. This report identifies several stocks that might benefit from recovering market conditions.
Market Observations for 2024 ?
Jefferies emphasized that the disparity between market winners and losers has expanded significantly, a situation they do not anticipate lasting much longer. The firm’s team of analysts pointed out that smaller-cap companies are trading at roughly 2.6 times their sales, while mid-cap firms are priced at around 3.2 times sales. They believe that current momentum in the market has softened and predict that there may be additional room for improvement.
Subscribe to our Social Media for Exclusive Crypto News and Insights 24/7!
- Analysts see the gap between last year’s outperformers and underperformers narrowing.
- Jefferies has identified several stocks rated as buys despite their poor performance last year.
Align Technology’s Recovery Prospects ?
Align Technology experienced a significant decline of 23.9% in 2024, yet analysts sense a possible turning point. Year-to-date, the medical device company has encountered a slight drop of over 3%. Following the release of their earnings report, the stock gained approximately 1% even after the company fell short of earnings and revenue expectations for the fourth quarter.
Align anticipates minimal revenue growth in the low single digits compared to last year. The firm’s note indicates a stabilization in case volume on a global scale, although they remain cautious due to the sluggish state of the dental market. Jefferies has set a price target of $260 for Align, reflecting a potential upside of over 28% from its closing price earlier this week. Analysts also highlight the importance of Align’s innovation pipeline, which includes promising new products like the Invisalign Palatal Expander and the next-generation Lumina scanner expected to support growth in the upcoming fiscal year.
- A majority of Wall Street analysts exhibit a bullish sentiment towards Align Technology.
- Only 7 out of 18 analysts currently have a hold rating; the remaining display a strong buy or buy rating.
- The consensus target price for Align stands at $258, implying an upside potential of over 27%.
Valvoline’s Positive Outlook ?
Valvoline, an automotive services provider, recorded a decline of 3.7% last year; however, early indications in 2025 show that the stock has been outperforming the general market with gains surpassing 5%. During the same time, the S&P 500 index has appreciated by over 4%. Jefferies has issued a target price of $49 for Valvoline, suggesting a potential upside of over 35%.
Jefferies views Valvoline favorably this year due to steady industry advantages driven by increasing vehicle park (PARC) and elevated vehicle miles traveled (VMT). The firm also underscores Valvoline’s market share growth in the fragmented quick lube sector, driven by new unit openings and enhanced customer service investments. The company has planned for 160 to 185 new units in its fiscal guidance, further contributing to its favorable outlook.
- Seven out of fifteen analysts have rated Valvoline as a strong buy or buy.
- The consensus target price for Valvoline approximates $44, signaling over 22% upside potential.
Celsius’ Recovery from Significant Decline
Celsius, a beverage company, has faced a staggering fall of 51.7% in 2024. Despite this decline, stocks have decreased by just over 2% this year, but a notable surge of 12% occurred on Wednesday ahead of its fourth-quarter earnings announcement scheduled to release after the market closes on Thursday.
The upcoming earnings report may play a pivotal role in determining Celsius’s trajectory. Observers are keen to see if the company can bounce back from its previous performance, with all eyes focused on how it will handle current market challenges.
- The drastic declines in Celsius’s stock have raised questions about its recovery.
- Any positive news from its upcoming earnings could signal a change in momentum.
As we move further into this year, keep an eye on these companies as they navigate market conditions that may present new opportunities for growth.
